Compare OGS & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OGS | RGEN |
|---|---|---|
| Founded | 1906 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil/Gas Transmission | Medical/Dental Instruments |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 6.6B |
| IPO Year | 2013 | 1995 |
| Metric | OGS | RGEN |
|---|---|---|
| Price | $78.40 | $122.31 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 12 |
| Target Price | $89.00 | ★ $167.67 |
| AVG Volume (30 Days) | 564.3K | ★ 1.2M |
| Earning Date | 05-04-2026 | 05-05-2026 |
| Dividend Yield | ★ 3.10% | N/A |
| EPS Growth | 11.76 | ★ 286.96 |
| EPS | ★ 2.04 | 0.15 |
| Revenue | ★ $2,578,005,000.00 | $141,236,000.00 |
| Revenue This Year | $12.51 | $14.30 |
| Revenue Next Year | N/A | $14.52 |
| P/E Ratio | ★ $37.89 | $844.20 |
| Revenue Growth | ★ 42.54 | 35.10 |
| 52 Week Low | $70.87 | $100.99 |
| 52 Week High | $90.78 | $175.77 |
| Indicator | OGS | RGEN |
|---|---|---|
| Relative Strength Index (RSI) | 36.68 | 54.31 |
| Support Level | $76.95 | $121.25 |
| Resistance Level | $79.23 | $131.53 |
| Average True Range (ATR) | 1.52 | 5.91 |
| MACD | -0.29 | 1.46 |
| Stochastic Oscillator | 33.50 | 74.44 |
ONE Gas Inc is a regulated natural gas utility company. It is involved in the distribution and sale of natural gas to residential, commercial, industrial, and transportation consumers through its network of pipelines and service lines. Almost all of the company's revenue is derived from natural gas sales in the states of Oklahoma, Kansas, and Texas. It operates in one reportable business segment: regulated public utilities that deliver natural gas to residential, commercial, and transportation customers.
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.